Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.
Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular Repair™ products, announced the commercial availability of the Xclose™ Plus Tissue Repair System at the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves meeting in Orlando, Florida.
DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC (“DJOFL”), for the fourth quarter and fiscal year ended December 31, 2009. ReAble Therapeutics, Inc. (“ReAble”) acquired DJO Incorporated (“DJO Opco”) in a transaction completed on November 20, 2007 (the “DJO Merger”).
Patients who are deaf or hard-of-hearing, who seek treatment at the Orthopedic Institute of Pennsylvania, will receive qualified interpreters when needed for effective communication as required by federal law under a Settlement Agreement reached with the U.S. Department of Health and Human Services.
While lower back pain ranks as a common cause of disability in the United States, determining what causes a person's back pain is often challenging. A new Cochrane review on diagnosing back pain finds that no single diagnostic test is good at discriminating between patients who have a herniated disc and patients who do not, according to lead author Danielle van der Windt.
BioMimetic Therapeutics, Inc. today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA. The Company previously announced the filing of both the pre-clinical pharmacology/toxicology and quality/manufacturing modules with the FDA in June of 2009.
Small Bone Innovations, Inc., a leading, privately-held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, is making available to hand surgeons a new 10-minute new surgical technique DVD showing an innovative volar approach to insertion of its SR™ PIP (Proximal Interphalangeal) implant.
A "metal foam" that has a similar elasticity to bone could mean a new generation of biomedical implants that would avoid bone rejection that often results from more rigid implant materials, such as titanium.
According to a new global report series by iData Research (www.idataresearch.net), the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for orthopedic biomaterials grew by 11.5% in 2009 and is estimated to reach almost $6.3 billion by 2016.
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.
St. Joseph's Hospital-North, part of BayCare Health System, offers emergency care, surgical services, imaging and diagnostic facilities, intensive care and more in a peaceful, healing and family-centered environment. Located just north of Tampa in Lutz, the all-digital, state-of-the-art facility is specially designed to make patients and visitors as comfortable as possible during their hospital experience.
Minority patients in New York City appear less likely than white patients to have surgeries performed by surgeons or at facilities that have handled large numbers of similar procedures in the past, according to a report in the February issue of Archives of Surgery, one of the JAMA/Archives journals.
Stematix, Inc. (Houston, USA), a regenerative medicine provider positioned to accelerate safe and effective global use of stem cell therapies, announced today that it entered into a 10-year exclusive agreement with Laboratorios Bagó (Buenos Aires, Argentina), a leading Argentine medical products company.
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.
Patients with orthopedic and autoimmune conditions expect Hospital for Special Surgery --because of its leadership role--to deliver the highest quality care. To further accomplish this mission, HSS is announcing the creation of a Quality Research Center with an innovative structure for applying research methodologies to health-care quality issues.
Bacterin International, Inc. (Bacterin), a developer of biological scaffolds for orthopedic indications, today announced the completion of a $3 million private placement of Secured Convertible Promissory Notes led by Middlebury Securities, LLC.
Grant Medical Center recently completed the nation's first published study of a new procedure that may give hope to millions of patients facing lower limb amputations from peripheral arterial disease (PAD). PAD is a painful circulatory problem in the legs that affects 10 million Americans. If left untreated, it can lead to serious complications such as stroke, amputation and death.
Javelin Pharmaceuticals, Inc. today announced that a reexamination conducted by a third party of pain score measurements from its Phase III study of Ereska™ (intranasal ketamine) showed that top line results for its primary endpoint were statistically significant. Previously, Javelin had reported that the top line results for its primary endpoint were not statistically significant.
RTI Biologics Inc., the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage procedures for victims of the recent natural disasters in Haiti.
Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.
According to the Centers for Disease Control and Prevention, 46 percent of children admitted to trauma centers for winter sports injuries have been diagnosed with a head injury – the majority of them from snowboarding, sledding, skiing, ice skating or ice hockey. Pediatric sports medicine is a growing field and is a direct response to how active today’s children are in competitive and recreational sports.